Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation.
Saved in:
| Title: | Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation. |
|---|---|
| Authors: | Li, Duo1 (AUTHOR), Zhong, Qi1 (AUTHOR), Xiao, Di1 (AUTHOR), Wang, Weifan1 (AUTHOR), Xie, Lejing1 (AUTHOR), Peng, Mei1 (AUTHOR), Xu, Cangcang1 (AUTHOR), Wu, Huaying1 (AUTHOR), Li, Zhuan1 (AUTHOR) zhuanli@hunnu.edu.cn, Yang, Xiaoping1 (AUTHOR) xiaoping.yang@hunnu.edu.cn |
| Source: | Cancer Cell International. 10/17/2025, Vol. 25 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
